Search Results - Shuttleworth, Stephen Joseph

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Design and Development of a Novel Orally-Active, PI3K-p110Beta/Delta Inhibitor with Combined Tumor Immunotherapeutic, Growth Inhibition and Anti-Metastatic Activity

    Design and Development of a Novel Orally-Active, PI3K-p110Beta/Delta Inhibitor with Combined Tumor Immunotherapeutic, Growth Inhibition and Anti-Metastatic Activity by Shuttleworth, Stephen Joseph

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Abstract 2366: Targeting PI3 pathway in ibrutinib resistant diffuse large B-cell lymphoma

    Abstract 2366: Targeting PI3 pathway in ibrutinib resistant diffuse large B-cell lymphoma by Jain, Neeraj, Sehgal, Lalit, Shuttleworth, Stephen Joseph, Samaniego, Felipe

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Felipe Samaniego

    Felipe Samaniego by Jain, Neeraj, Sehgal, Lalit, Davis, R. Eric, Shuttleworth, Stephen Joseph, Samaniego, Felipe

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Results of a First in Human, Dose Ascending, Phase I Study Examining the Safety and Tolerability of KA2237, an Oral PI3K p110β/δ Inhibitor in Patients with Relapsed/Refractory (R/R) B-Cell Lymphoma

    Results of a First in Human, Dose Ascending, Phase I Study Examining the Safety and Tolerability of KA2237, an Oral PI3K p110β/δ Inhibitor in Patients with Relapsed/Refractory (R/R... by Nastoupil, Loretta J., Neelapu, Sattva S, Davis, Eric, Samaniego, Felipe, Fowler, Nathan H, Westin, Jason R., Lee, Hun Ju, Wang, Michael, Hagemeister, Fredrick B., Beer, Philip, Cecil, Alexander R.L., Dow, James, McHale, Duncan, Silva, Franck, Ward, Penny, Yavari, Arash, Shuttleworth, Stephen Joseph

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Pre-Clinical Evaluation of the PI3K-p110β/δ Inhibitor KA2237 in Mantle Cell Lymphoma

    Pre-Clinical Evaluation of the PI3K-p110β/δ Inhibitor KA2237 in Mantle Cell Lymphoma by Huang, Shengjian, Nastoupil, Loretta J., Guo, Hui, Bell, Taylor, Ahmed, Makhdum, Li, Carrie J, Wang, Jack, Liu, Yang, Zhang, Victoria, Kim, Caroline R, Boyle, Jordan N, Lorence, Elizabeth A, Lam, Laura T, Chen, Zhihong, Zhang, Hui, Shuttleworth, Stephen Joseph, Nomie, Krystle, Wang, Michael, Zhang, Liang

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: